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Background: Uncontrolled asthma remains a frequent cause of emergency department (ED) visits and hospital
admissions. Improper asthma inhaler device use is most likely one of the major causes associated with uncontrolled
asthma and frequent ED visits.
Objectives: To evaluate the inhaler technique among asthmatic patients seen in ED, and to investigate the
characteristics of these patients and factors associated with improper use of inhaler devices and its relationship with
asthma control and ED visits.
Methods: A cross-sectional study of all the patients who visited the ED with bronchial asthma attacks over a 9-
month period was undertaken at two major academic hospitals in Saudi Arabia. Information was collected about
demographic data and asthma management and we assessed the inhaler techniques for each patient using an
inhaler technique checklist.
Results: A total of 450 asthma patients were included in the study. Of these, 176(39.1%) were males with a mean
age of 42.3 ±16.7 years and the mean duration of asthma was 155.9 ± 127.1 weeks. The improper use of asthma
inhaler devices was observed in 203(45%) of the patients and was associated with irregular clinic follow-ups
(p = 0.0001), lack of asthma education (p = 0.0009), uncontrolled asthma ACT (score ≤ 15) (p = 0.001), three or
more ED visits (p = 0.0497), and duration of asthma of less than 52 weeks (p = 0.005). Multiple logistic regression
analysis revealed that a lack of education about asthma disease (OR =1.65; 95% CI: 1.07, 2.54) or a lack of regular
follow-up (OR =1.73; 95% CI: 1.08, 2.76) was more likely to lead to the improper use of an asthma inhaler device.
Conclusion: Improper asthma inhaler device use is associated with poor asthma control and more frequent ED
visits. We also identified many avoidable risk factors leading to the improper use of inhaler devices among asthma
patients visiting the ED.
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Table 1 Inhaler device check list
Use of a pressurized metered-dose inhaler
1. Shake the canister
2. Hold the canister upright at opening of mouth
3. Begin a slow breath
4. Actuate the MDI once while continuing with a slow breath
5. Inhale to total lung capacity
6. Hold breath for at least 4 seconds
MDI with spacer
1. Remove the cap of the spacer.
2. Remove the cap of the puffer. Shake the puffer 5 or 6 times.
3. Insert the puffer in the hole at the back of the spacer.
4. Blow all your breath out until lungs are empty.
5. Insert the spacer mouthpiece into the mouth
6. Press the down once on the puffer's canister.
7. Slowly breathe in from the spacer full breath.
8. Hold your breath for at least 4 seconds
Using the turbuhaler
1. Unscrew the cover and remove it.
2. Holding the Turbuhaler upright, turn the colored wheel one way
and back the other way until it clicks.
3. Breathe out normally.
4. Put the mouthpiece between your lips and tilt your head back slightly.
5. Breathe in deeply and forcefully.
6. Hold your breath for 10 seconds
Diskus
1. Open the device
2. Slide the lever
3. Exhale away from device, to empty lung
4. Place mouthpiece between teeth and lips
5. Inhale rapidly and fully
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Asthma is a chronic inflammatory disease of the airways
associated with bronchial hyper-responsiveness and
reversible airflow obstruction [1,2]. The incidence and
prevalence of asthma have increased during the past
20 years, affecting 5-10% of the global population
[3,4]. The prevalence of bronchial asthma among
Saudi patients is approximately 20-25% [4,5]. The primary
goal of asthma treatment is to control symptoms and to
reduce emergency department (ED) use for acute asthma
treatment [1,6-8]. One study reported only 5% asthma
control among patients seen at tertiary care hospital [9].
Poor asthma control remains a frequent cause of ED pres-
entation and hospital admission [10], and the cost of un-
controlled asthma care is substantial. For example, ED use
for asthma management accounts for almost one-third of
all asthma costs in the United States [11]. The administra-
tion of corticosteroids via inhalation is considered the
optimal route for appropriate drug delivery for treatment
of bronchial asthma and could reduce asthma hospitaliza-
tions by as much as 80% [12]. The most important advan-
tage of inhaled therapy is the direct, localized delivery of a
high concentration of drugs to the airways with minimal
systematic side effects [13]. However, improper inhaler
device use is one of the most common causes that hinder
better asthma control [14-18].
The improper use of inhaled devices in the management
of bronchial asthma decrease drug delivery, patient’s adhe-
rence to the treatment regimen and drug effectiveness. This
subsequently leads to uncontrolled asthma management
and multiple ED visits [14,15,17-22]. The improper inhaler
device use as a cause of uncontrolled asthma management
and frequent ED visits, to best of our knowledge, had never
previously been studied in the Saudi population. The
objective of this study was to evaluate the inhaler technique
among asthmatic Saudi patients seen in ED and to identify
the characteristics of these patients along with factors asso-
ciated with the improper use of inhaler devices, asthma
control and the number of ED visits.
Methods
This cross-sectional study was conducted at the King
Abdulaziz Medical City – King Fahad National Guard
Hospital in Riyadh (KAMC-KFNGH) and the King
Khalid University Hospital (KKUH). We enrolled adult
patients (≥ 18 years old) diagnosed with asthma who
visited the ED for asthma management between August
2010 and March 2011. The enrolled patients had a docu-
mented diagnosis of bronchial asthma as diagnosed by
their primary physician and were on a prescribed inhaled
corticosteroid (ICS) therapy for at least the last three
months. We excluded patients without a documented
diagnosis of bronchial asthma and those who were not
prescribed ICS according to their medical records.This study was approved by the Institutional Review
Board (IRB) (Ref. IRBC/123/11). During the ED visit, a
trained co-investigator collected information about
demographic data, the duration of the illness and the
medication used for asthma therapy. Additionally, the
data were gathered on whether the patient received any
formal education about asthma as a disease and, how to
use their inhaler devices. The co-investigators also veri-
fied this information by reviewing the medical record of
the patients and they assessed the asthma control over
the last month by administering a validated published
Arabic version of the Asthma Control Test (ACT)[23].
The co-investigators also determined whether the
patient knew how to use the prescribed inhaler properly
following specific steps in the check list (Table 1). All
patients were observed for two trials of using their
inhalers and proper use was identified if the patient
Table 2 Demographics and clinical characteristics about
bronchial asthma (N=450)
Characteristics Levels N (%) ╦
Age, (Mean ± SD) 42.3 ± 16.7
Duration of illness in weeks, (Mean ± SD) 155.90 ±
127.13
Duration of illness, n(%) > 1 Year 429 (95.97)
Gender, n(%) Female 274 (60.9)
Marital status Married 371 (83.6)
Improper use of asthma inhaler devices 203 (45.0)





Follow-up consistently with doctor 270 (60.0)







No education about asthma 232(51.6)
No education about medication 183(40.7)
ER visits ≥3 165(36.7)








Received health education about asthma
disease from a physician
200 (44.5)
Received health education about asthma
disease from a health educator
35(7.8)
Received health education about asthma
disease from a pharmacist
21(4.7)










╦All percentages were rounded to one decimal place.
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consent was obtained from all participants.
Statistical analysis
The data collected was transferred and analyzed using
SAS® versions 9.2 (SAS Institute Inc., Cary, NC).
Descriptive statistics, such as the means and standard
deviations, were used to summarize the quantitative
variables. The frequencies and percentages were used
to summarize categorical variables. Chi-squared tests
were used to test the association between clinical
characteristics across the variables regarding asthma device
use and asthma control test. P-values less than 0.05 were
considered significant. Multiple logistic models were used
to identify the risk factors that were associated with the
improper use of asthma inhaler devices. The odds ratios
(ORs) with 95% CIs were reported to describe the strength
of these associations.
Results
Among the 450 asthma patients, 176 (39.1%) were male
(Table 2). The mean age was 42.3 ±16.7 and the mean
duration of asthma was 155.9 ± 127.1 weeks. There were
270 (60%) patients with regular physician follow-up.
Approximately half of the patients, 232 (51.6%) had no
formal asthma education as a disease and 183 (40.7%)
had no formal education about the medications or the
asthma inhaler devices by any health care professional.
Of the patients who received asthma and device educa-
tion, 200 (44.5%) were educated by physicians, 35 (7.8%)
were educated by asthma educators, and 21 (4.7%) were
educated by the pharmacists. A total of 165 (36.7%)
patients had three or more ED visits per year. Asthma
control in the month preceding the ED visit (as per the
ACT) was as follows: uncontrolled (ACT ≤ 15) was 105
(23.3%), partial control (16 ≥ ACT ≤ 23) was 335
(74.4%), complete control (ACT ≥ 24) was 8 (1.8%), and
missing ACT 2(0.5%).
The improper use of asthma inhaler devices was
observed in 203 (45%) of the patients. The improper use
had a significant association with irregular clinic follow-
ups, lack of education about asthma medication, lack of
education about asthma as disease, uncontrolled asthma,
and three or more ED visits (See Table 3). The patients
with irregular clinic follow-up compared with regular
follow-up were more likely to misuse the asthma device
(60.9% versus 34.8%, p = 0.0001). Patients who received
no education about asthma medication compared with
those who did were more likely to use an asthma device
improperly (54.6% versus 38.7%, p = 0.0009). Patients
with uncontrolled ACT (score ≤ 15) compared to
partially/fully controlled ACT (score > 15) were more
likely to use asthma device improperly (59.1% versus
40.8%, p =0.001). Patients with 3 or more ED visitsbecause of asthma exacerbations were more likely to
improperly use an asthma device compared to those who
visited less than 3 times (50.9% versus 41.3%, p =0.0497).
Moreover, patients who were diagnosed with asthma for
less than 1 year were more likely to use an asthma device
Table 3 The association of asthma device use with demographic and clinical characteristics
Characteristics Levels Improper 203 (45%) Proper 247 (55%) P-value
Gender Female 123(44.9) 151(55.1) 0.9066
Age ≥ 45 Years 82(49.7) 83(50.3) 0.1369
Follow up with doctor Yes 94(34.8) 176(65.2) 0.0001*
No 109(60.9) 70(39.1)
Educational level High school or less 173(44.7) 214(55.3) 0.5884
Education about medication Yes 103(38.7) 163(61.3) 0.0009*
No 100(54.6) 83(45.4)
Education about asthma Yes 71(32.7) 146(67.3) 0.0001*
No 132(56.9) 100(43.1)
ACT Uncontrolled 62(59.1) 43(41.0) 0.0010*
Full/Partially controlled 140(40.8) 203(59.2)
ED visits ≥ 3 84(50.9) 81(49.1) 0.0497*
< 3 114(41.3) 162(58.7)
Duration of asthma >1 Year 188(43.8) 241(56.2) 0.0046*
≤1 Year 14(77.8) 4(22.2)
Received health education about asthma disease from a physician
Yes 60(30.0) 140(70.0) 0.0001*
No 143(57.4) 106(42.6)
Received health education about asthma disease from a health educator
Yes 14(40.0) 21(60.0) 0.5188
No 189(45.7) 225(54.4)
Received health education about asthma disease from a pharmacist
Yes 6(28.6) 15(71.4) 0.1166
No 197(46.0) 231(54.0)
Knew about asthma disease independently
Yes 11(40.7) 16(59.3) 0.6302
No 192(45.5) 230(54.5)
Device MDI 189(45.7) 225(54.4) 0.6958
Turbuhaler 6(46.2) 7(53.9)
MDI with spacer 6(31.9) 13(68.4)
Diskus 2(50.0) 2(50.0)
*The Chi-square/Fisher exact statistic is significant at the .05 level.
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more than 1 year (77.8% versus 43.8%, p =0.005). Not
receiving health education about asthma disease from a
physician is associated with misuse of the device (57.4%
versus 30.0%, p =0.0001). Also, our analyses show that this
improper use of the device was not associated with gender,
age, or education level (p > 0.05). After controlling for all
other factors, four risk factors were found to be associated
with improper use of the devices: uncontrolled asthma,
irregular use of ICS, irregular follow up with clinic and lack
of education about asthmatic disease (p < 0.05; Table 4).
Additionally, we found patients who lacked asthma educa-
tion were more likely to use the asthma device improperly
compared with the group who received education (OR:1.65; 95% CI: 1.07, 2.54). Patients who did not follow-up
regularly with clinical appointments were also more likely
to improperly use asthma devices than those who regularly
followed-up (OR: 1.726; 95% CI: 1.081, 2.756). This study
also revealed that patients with an uncontrolled ACT
(score ≤ 15) were 7 times more likely to use inhaler devices
improperly compared with patients with fully controlled
ACT (OR: 7.414; 95% CI: 1.345, 40.857).
Discussion
Previous studies have shown that the improper use of
inhaler devices decreases drug delivery, patient’s regimen
adherence and drug effectiveness contributes to uncon-
trolled asthma and multiple ED visits [14,15,17-22]. In
Table 4 The odds ratios with 95% CIs for risk factors associated with improper use of an asthma device
Variable Reference Estimate SE P-value OR 95% CI on OR
Intercept −0.5351 0.2924 0.0673
Uncontrolled ACT Full control 0.8778 0.3177 0.0057* 7.414 1.345 40.857
Partially controlled ACT Full control 0.2477 0.3005 0.4097 3.948 0.743 20.983
ICS regular Regular 0.4322 0.1160 0.0002* 2.374 1.506 3.740
No education about asthma disease Education about asthma disease 0.2514 0.1100 0.0223* 1.653 1.074 2.544
No follow-up with doctor Follow-up with doctor 0.2730 0.1193 0.0221* 1.726 1.081 2.756
* Wald Chi-Square statistic is significant at the .05 level.
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improper inhaler device use, asthma control and number
of ED visits. To the best of our knowledge, this is the
first study in Saudi Arabia to examine the factors
possibly leading to improper asthma inhaler use. We be-
lieve that this study has a sound methodology, being
conducted by personal interview, and patient informa-
tion was confirmed by reviewing medical records for
each patient. A trained investigator confirmed the
inhaler device use against a standard checklist. Similar
to other studies, this study demonstrated that improper
inhaler use is common in our population and results
from avoidable causes. Furthermore, we demonstrated that
improper inhaler device use is associated with poor asthma
control and frequent ED visits [17-22]. Interestingly,
improper asthma device use is mainly due to a lack of
knowledge regarding asthmatic disease.
In this study, a majority (92%) of the patients were using
metered-dose inhalers (MDI). This finding is consistent
with Saudi Arabian practice for this disease, as most of the
patients were seen at primary health care and family medi-
cine clinics where the most common form of inhalers are
MDIs. However, this should not be accepted as the cause
for improper inhaler use. In fact, studies have shown that
newer dry powder inhalers (DPIs) are not associated with
an improved inhalation technique. Devices should be
selected based on a patient’s acceptance and preferences
[16]. Selecting a device based on the patients’ preference is
cost effective in the long term, even if the device is more
expensive than the standard devices [24]. However, studies
have shown that good educational practice results in the
proper use of MDI which will be more cost effective in the
long-term [16,25,26].
Importantly, we found that 40% of the patients did not
receive any formal education by any health care profes-
sionals regarding the proper use of inhaler devices. This
was mostly due to a lack of asthma education programs.
Almost half of our patients used asthma devices improp-
erly, resulting in more visits to the ED due to subse-
quently poor asthma control. The major avoidable
factors for improper device use were a lack of education
regarding asthma as a disease and how the patient useinhaler device correctly. Therefore, our health care sys-
tem should emphasize establishing asthma education
programs to educate patients on asthma and its manage-
ment, particularly regarding the use of inhaler devices.
These asthma education programs require continuous
effort to educate patients and their caregivers. Studies
have shown that standardized asthma education
programs, education focused on self-management and
behavioral change improves inhaler device use, adhe-
rence to treatment and asthma control [27,28]. Studies
have shown that almost 50% of the patients used the
devices correctly and this improved to more than 80%
after instruction regardless of the device being used
[29,30]. In this study, approximately 59% of the patients
received education about how to use the inhaler devices.
The education was given by physicians in 44% of cases.
However, 30% still improperly used the medication.
Furthermore, asthma educators and pharmacists only
educated approximately 6-7% of patients about the proper
use of inhalers. Similar to other studies, there was no
difference in the appropriate use of device stratified by
patient age or gender [31].
One limitation of our study was the documentation of
specific education that was given to the patients. We
had to rely on the patients’ recollection of the education,
as the education was not documented in the medical
records. Additionally, we were not able to evaluate the
quality of the teaching and how many educational ses-
sions our patients received by health care professionals.
We also had no background information on the psycho-
social factors of this group of patients with poor inhaler
device use, as this was beyond the scope of our study.
Another limitation of this study was that we did not
assess the side effects of improper inhaler use and how
much this might contribute to poor compliance with
medication, asthma control and ED visits. However,
studies have shown that trained asthma educators,
respiratory therapists and pharmacists are better quali-
fied to teach patients than other health care providers
[32,33]. We previously documented that only 5% of our
patients seen at tertiary care clinics are completely in
control of their asthma [9], and we also documented that
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about asthma pathophysiology and inhaled steroid use
[34]. Also, in this study we only assessed the essential
steps required for proper drug delivery. We did not score
each step separately or count the number of errors or
omissions. In addition to our previous studies [9,34], the
finding of this study clearly demonstrates some limitations
in our health care system. There is an urgent need for a
national asthma education program at all level of medical
care. We believe that the lack of an appropriate asthma
education program in our system leads to improper device
use, lack of the patient’s knowledge about asthma, false
beliefs and misconceptions about ICS. These deficiencies
result in poor asthma control and increased ED visits.
This study was limited to two academic centers in the
Riyadh-central region. Most likely it does not represent
the asthma care at the national level; thus, there is a need
for national epidemiological studies to assess different
aspects of asthma management.
Conclusion
This study shows that improper asthma inhaler technique
is common among patients visiting ED in tertiary care cen-
ters in Saudi Arabia. This improper technique is associated
with poor asthma control and frequent ED visits. The lack
of appropriate asthma education is likely a major cause of
improper device use. Furthermore, national asthma studies
are necessary to explore this problem and to prospectively
study the value of an interventional asthma education
program to improve asthma inhaler device use and clinical
treatment outcomes.
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